title: Bacteriological and cytological findings during the late puerperal period after two different treatments of retained placenta followed by acute puerperal metritis.
abstract: The aim of the study was to compare the effect of two acute puerperal metritis (APM) treatment protocols on uterine condition during the late puerperal period (5th to 7th week). Late gestation healthy cows (n = 21) were divided randomly in three equal groups. Parturitions were induced. Treatments of APM were started on the third day postpartum (PP). Group A was treated with an oxytocin analogue carbetocin for three days and intrauterine administration of cephapirin between days 15 and 17. Group B was given intramuscular injection of ceftiofur for five days followed by two injections of prostaglandin F2alpha, at an interval of 12 h, on the eighth day PP. Group C served as the control group with no treatment. Body temperature was recorded daily for 14 days PP. Uterine biopsies for bacteriology, and uterobrush samples for cytology, were taken once a week from the 5th to 7th week postpartum. No differences were found in body temperature on day 14 PP, presence of bacteriological infections and disappearance of uterine inflammatory signs diagnosed by cytological examination between experimental groups.
authors.affiliation: Department of Therapy, Institute of Veterinary Medicine and Animal Sciences, Estonian University of Life Sciences, Tartu, Estonia. tjulia@emu.ee
authors.forename: Julia
authors.initials: J
authors.lastname: Jeremejeva
authors.forename: Toomas
authors.initials: T
authors.lastname: Orro
authors.forename: Merle
authors.initials: M
authors.lastname: Valdmann
authors.forename: Kalle
authors.initials: K
authors.lastname: Kask
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001831:Body Temperature / Q000276:immunology; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D002511:Cephalosporins / Q000627:therapeutic use; D002514:Cephapirin / Q000627:therapeutic use; D015237:Dinoprost / Q000627:therapeutic use; D005260:Female; D006651:Histocytochemistry / Q000662:veterinary; D010121:Oxytocin / Q000031:analogs & derivatives / Q000627:therapeutic use; D018457:Placenta, Retained / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D011247:Pregnancy; D011645:Puerperal Infection / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D011897:Random Allocation; D014599:Uterus / Q000187:drug effects / Q000276:immunology / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010121:Oxytocin; C053503:ceftiofur; C020731:carbetocin; D002514:Cephapirin; D015237:Dinoprost